In congestive hearf failure, increased secretion of afrial nafriurefic pepfide (ANP) is an important compensatory mechanism that unloads the failing heart and promofes renal salt and wafer excretion. However, acfivafion of opposing sodium-refaining facfors, parficularly the renin-angiofensin sysfem, reduces renal responsiveness to A NP and shifts the cardiovascular sysfem to a state of decompensafion. M ore than a decade has elapsed since the original description by de Bold and coworkers (6) of the potent natriuretic activity present in extracts of rat atria. Since then, major advancements have taken place in our understanding of the role of the heart's hormonal system, in both physiological and pathophysiological conditions (4). Atrial natriuretic peptide (ANP), the 28-amino acid residue peptide of cardiac origin, is the most familiar and thoroughly studied member of a family of natriuretic peptides containing at least two other members, brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP), encoded by different, independent genes. The biological actions of the natriuretic peptides are mediated by binding of the peptide to specific membrane receptors (ANP, and ANP,) followed by activation of an intracellular signal transduction system using guanosine 3',5'-cyclic monophosphate (cGMP) as a second messenger.
An additional class of receptor has been identified that is not coupled to guanylate cyclase and apparently serves to clear the hormone from the circulation (ANP, receptor).
Inactivation of the hormone is also achieved enzymatically by neutral endopepti- ANP in congestive heart failure Perturbations in the ANP system have been described in several pathophysiological conditions associated with abnormal regulation of body fluids and blood pressure control, particularly in edematous disorders (4). Congestive heart failure (CHF) is, perhaps, the most widely recognized pathological entity that involves aberrations in the ANP system. Although initially considered to be a state of "ANP deficiency," it soon became evident, based on direct measurements of plasma levels of the hormone, that circulating ANP levels were markedly elevated in CHF (5) (Fig. 1) . In fact, the highest concen- ancy, such as the appearance of abnormal (less active) circulating forms of the peptide (P-ANP) and inadequate secretory reserves to the degree of heart failure (i.e., relative ANP deficiency). However, because circulating levels of the native biologically active form of ANP are clearly elevated in CHF, those factors cannot account for the avid salt and water retention.
Rather, it appears that in CHF the kidney becomes less responsive to the natriuretic action of the endogenous hormone.
Indeed, we believe that the development of renal hyporesponsiveness (and in severe cases refractoriness)
to the renal effects of the hormone represents a critical turning point in the development of salt retention and edema formation in CHF.
Renal hyporesponsiveness to ANP in CHF retaining factors, rather than the action of a single system, that determines the final rate of urinary salt and water excretion in CHF. The kidney integrates the signals from several opposing as well as synergistic systems, through a variety of tubular and hemodynamic mechanisms, to yield the final excretion of sodium and water.
The notion of a dynamic equilibrium between natriuretic and sodium-retaining factors ultimately determining renal sodium excretion also provides a rationale for pharmacological intervention to correct the imbalance present in heart failure. Thus a shift in the balance in favor of natriuresis may be achieved by either increasing the activity of the natriuretic factors or reducing the influence of the antinatriuretic systems. In the interplay between the RAAS and ANP in CHF, first transport system found to be enzymatic in nature, continues to captivate biologists from different disciplines.
Ubiquitously expressed in virtually all cells (Fig. I) , the enzyme utilizes the energy derived from ATP hydrolysis to effect the active countertransport of Na+ and K+ across the plasma membrane.
The electrochemical gradients generated by extrusion of Na+ from and uptake of K+ into the cell are essential for Volume
